TABLE 5

Patients administered with prescribed atomoxetine

NumberPatient Age in Years, Sex (Weight)Time after Last Administration (Morning/Evening Dose, mg)CYP2D6 Genotype
112, Male (30 kg)1.3 h (25/25 mg)*10-*36/*10-*36
210, Male (28 kg)2.0 h (25/25 mg)a*1/*1
314, Female (50 kg)1.5 h (30/30 mg)*1/*10
49, Female (36 kg)4.0 h (25/35 mg)*1/*2-*2
511, Male (41 kg)2.3 h (35/35 mg)*2-*2/*10
613, Female (40 kg)4.0 h (40/40 mg)b*2/*10-*36
713, Male (40 kg)5.5 h (35/35 mg)*10-*36/*36-*36
810 Male (25 kg)1.0 h (15/15 mg)*10-*36/*10-*36
910, Male (33 kg)4.0 h (20/20 mg)*1/*10
1010, Male (33 kg)1.8 h (20/20 mg)*2/*10
118, Male (29 kg)1.5 h (25/25 mg)*1/*5
1213, Male (50 kg)2.5 h (40/50 mg)c*10-*36/*36-*36
1313, Male (36 kg)6.5 h (20/25 mg)d*10-*36/*10-*36
  • aUrine sample was collected 4 hours after last administration in the morning.

  • bUrine sample was collected 11 hours after last administration in the morning.

  • cUrine sample was collected 2.5 hours after last administration in the morning.

  • dUrine sample was collected 6.5 hours after last administration in the morning.